Related Experiment Video
Updated: Jul 15, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular
Jan Lost1,2, Tej Verma1, Leon Jekel1
1From the Department of Radiology and Biomedical Imaging (J.L., T.V., L.J., M.v.R., N.T., S.M., G.C.P., R.B., A.G., M.A.H., H.S., W.B., B.V.M.-N., A.A., M.L., M.A.), Yale School of Medicine, New Haven, Connecticut.
Machine learning algorithms show promise in predicting glioma molecular subtypes from MRI scans, achieving high accuracy. However, limited external validation and significant bias risk hinder immediate clinical application.
Area of Science:
- Neuro-oncology
- Medical Imaging
- Machine Learning
Background:
- Glioma molecular subtypes are crucial prognostic indicators for patient survival and treatment decisions.
- Current pathology-based molecular diagnosis is invasive and limits neoadjuvant therapy options due to tumor heterogeneity.
Approach:
- A systematic review was conducted to identify and evaluate algorithms predicting glioma molecular subtypes using Magnetic Resonance (MR) imaging.
- 12,318 abstracts were screened, and 85 articles met inclusion criteria following PRISMA guidelines.
Key Points:
- Machine learning models demonstrated strong performance in predicting isocitrate dehydrogenase (IDH) mutation status (AUC 0.88 internal, 0.86 external) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation (AUC 0.79 internal, 0.89 external).
- Despite high accuracy in internal and limited external validation, all reviewed studies exhibited high bias according to the Prediction model Risk Of Bias Assessment Tool (PROBAST).
Conclusions:
- While AI-driven MR imaging shows potential for non-invasive glioma subtyping, widespread clinical adoption is challenged by insufficient external validation and inherent biases in current algorithms.
- Further research focusing on robust external validation and bias mitigation is essential for translating these predictive techniques into routine clinical practice.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024